The diagnostic impact of UK regional variations
The diagnostic influence of UK regional variations in age-specific prostate-specific antigen tips
The best prostate most cancers diagnostic pathway would maximise detection of clinically-significant prostate most cancers (csPCa) whereas avoiding pointless biopsies and different investigations. The introduction of pre-biopsy MRI has carried out a lot to help this aim. Nonetheless, referrals into the image-based diagnostic pathway nonetheless relies on prostate-specific antigen (PSA) testing carried out in main care and interpreted utilizing referral tips.
Within the UK, the Nationwide Institute for Well being and Care Excellence (NICE) solely offers steering on PSA thresholds for males aged 50-69 years (PSA ≥3.zero ng/mL) [1]. For different age teams, PSA thresholds are set by regional most cancers networks with none unified consensus. Right here we explored if completely different regional tips impacted csPCa detection in fashionable image-based pathways.
 CEACAM4 antibody |
|||
| MBS5302152-01mL | MyBiosource | 0.1mL | EUR 750 |
CEACAM4 antibody |
|||
| MBS5302152-5x01mL | MyBiosource | 5x0.1mL | EUR 3215 |
 CEACAM4 Antibody |
|||
| MBS7046400-005mL | MyBiosource | 0.05mL | EUR 190 |
CEACAM4 Antibody |
|||
| MBS7046400-01mL | MyBiosource | 0.1mL | EUR 270 |
CEACAM4 Antibody |
|||
| MBS7046400-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
CEACAM4 Antibody |
|||
| MBS7046630-005mL | MyBiosource | 0.05mL | EUR 190 |
CEACAM4 Antibody |
|||
| MBS7046630-01mL | MyBiosource | 0.1mL | EUR 270 |
CEACAM4 Antibody |
|||
| MBS7046630-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
 CEACAM4 Polyclonal Antibody |
|||
| 27275 | SAB | 100ul | EUR 439 |
CEACAM4 Polyclonal Antibody |
|||
| 27275-100ul | SAB | 100ul | EUR 302.4 |
CEACAM4 Polyclonal Antibody |
|||
| 27275-50ul | SAB | 50ul | EUR 224.4 |
 CEACAM4 polyclonal antibody |
|||
| BS74341 | Bioworld Biotech | 50ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
CEACAM4 Polyclonal Antibody |
|||
| E-AB-90053-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
CEACAM4 Polyclonal Antibody |
|||
| E-AB-90053-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
CEACAM4 Polyclonal Antibody |
|||
| E-AB-90053-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
CEACAM4 Polyclonal Antibody |
|||
| E-AB-90053-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
CEACAM4 Polyclonal Antibody |
|||
| E910055 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
 CEACAM4 Polyclonal Antibody |
|||
| MBS9130273-002mL | MyBiosource | 0.02mL | EUR 200 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9130273-005mL | MyBiosource | 0.05mL | EUR 255 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9130273-01mL | MyBiosource | 0.1mL | EUR 345 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9130273-02mL | MyBiosource | 0.2mL | EUR 545 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9130273-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |
CEACAM4 Polyclonal Antibody |
|||
| MBS8566242-01mL | MyBiosource | 0.1mL | EUR 305 |
CEACAM4 Polyclonal Antibody |
|||
| MBS8566242-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
| MBS8566242-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
| MBS8566242-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
| MBS8566242-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9431151-005mL | MyBiosource | 0.05mL | EUR 300 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9431151-01mL | MyBiosource | 0.1mL | EUR 390 |
CEACAM4 Polyclonal Antibody |
|||
| MBS9431151-5x01mL | MyBiosource | 5x0.1mL | EUR 1610 |
 OACA09101-50UL - CEACAM4 Antibody |
|||
| OACA09101-50UL | Aviva Systems Biology | 50ul | EUR 189 |
 OACA09102-50UL - CEACAM4 Antibody |
|||
| OACA09102-50UL | Aviva Systems Biology | 50ul | EUR 189 |
 OACA09101-100UL - CEACAM4 Antibody |
|||
| OACA09101-100UL | Aviva Systems Biology | 100ul | EUR 230 |
 OACA09102-100UL - CEACAM4 Antibody |
|||
| OACA09102-100UL | Aviva Systems Biology | 100ul | EUR 230 |
 CEACAM4 antibody - N-terminal region |
|||
| MBS3207675-01mL | MyBiosource | 0.1mL | EUR 455 |
CEACAM4 antibody - N-terminal region |
|||
| MBS3207675-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
 CEACAM4 Polyclonal Conjugated Antibody |
|||
| C27275 | SAB | 100ul | EUR 476.4 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
| MBS9439166-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
| MBS9439166-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
| MBS9439166-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
| MBS9439166-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
| MBS9439166-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
 Polyclonal CEACAM4 antibody - N-terminal region |
|||
| APR00954G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CEACAM4 - N-terminal region. This antibody is tested and proven to work in the following applications: |
|||
 ARP45182_P050-25UL - CEACAM4 Antibody - N-terminal region |
|||
| ARP45182_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
) ARP45182_P050 - CEACAM4 antibody - N-terminal region (ARP45182_P050) |
|||
| ARP45182_P050 | Aviva Systems Biology | 100ul | EUR 389 |
 CEACAM4 Rabbit pAb |
|||
| A10055 | Abclonal | 50μL | EUR 623.48 |
CEACAM4 Rabbit pAb |
|||
| A10055-100ul | Abclonal | 100 ul | EUR 369.6 |
CEACAM4 Rabbit pAb |
|||
| A10055-200ul | Abclonal | 200 ul | EUR 550.8 |
CEACAM4 Rabbit pAb |
|||
| A10055-20ul | Abclonal | 20 ul | EUR 219.6 |
CEACAM4 Rabbit pAb |
|||
| A10055-50ul | Abclonal | 50 ul | EUR 267.6 |
CEACAM4 Rabbit pAb |
|||
| E45R17690N | EnoGene | 50 ul | EUR 297.75 |
 Human CEACAM4 siRNA |
|||
| 20-abx911387 | Abbexa |
|
|
) CEACAM4 siRNA (Human) |
|||
| MBS829290-15nmol | MyBiosource | 15nmol | EUR 405 |
CEACAM4 siRNA (Human) |
|||
| MBS829290-30nmol | MyBiosource | 30nmol | EUR 565 |
CEACAM4 siRNA (Human) |
|||
| MBS829290-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
-Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4)) CEACAM4 (untagged)-Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
| SC303075 | Origene Technologies GmbH | 10 µg | Ask for price |
 CEACAM4 Blocking Peptide |
|||
| 33R-3092 | Fitzgerald | 100 ug | EUR 119 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CEACAM4 antibody, catalog no. 70R-7236 |
|||
 Antibody) Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| abx135973-01mg | Abbexa | 0.1 mg | EUR 175 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| 20-abx135973 | Abbexa |
|
|
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| abx322701-100g | Abbexa | 100 µg | EUR 350 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| 20-abx322701 | Abbexa |
|
|
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| abx322701-50g | Abbexa | 50 µg | EUR 250 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| abx321245-100g | Abbexa | 100 µg | EUR 350 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| 20-abx321245 | Abbexa |
|
|
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
| abx321245-50g | Abbexa | 50 µg | EUR 250 |
 - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4)) CEACAM4 (GFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
| RG220740 | Origene Technologies GmbH | 10 µg | Ask for price |
 Human CEACAM4 ELISA KIT |
|||
| ELI-11048h | Lifescience Market | 96 Tests | EUR 988.8 |
-Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4)) CEACAM4 (Myc-DDK-tagged)-Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
| RC220740 | Origene Technologies GmbH | 10 µg | Ask for price |
 Human CEACAM4 shRNA Plasmid |
|||
| 20-abx950782 | Abbexa |
|
|
 Human CEACAM4 Protein Lysate |
|||
| MBS139250-002mg | MyBiosource | 0.02mg | EUR 365 |
Human CEACAM4 Protein Lysate |
|||
| MBS139250-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
 Human Recombinant Protein) CEACAM4 (NM_001817) Human Recombinant Protein |
|||
| E45H34626M5 | EnoGene | 20 ug | EUR 785.42 |
) CEACAM4 Recombinant Protein (Human) |
|||
| RP051595 | ABM | 100 ug | Ask for price |
 (pORF)) CEACAM4 ORF Vector (Human) (pORF) |
|||
| ORF017199 | ABM | 1.0 ug DNA | Ask for price |
 Human CEACAM4 knockout cell line |
|||
| ABC-KH2892 | AcceGen | 1 vial | Ask for price |
|
Description: Human CEACAM4 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
 Human CEACAM4 knockdown cell line |
|||
| ABC-KD2892 | AcceGen | 1 vial | Ask for price |
|
Description: Human CEACAM4 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
 Human CEACAM4 Protein Lysate 20ug |
|||
| IHUCEACAM4PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human CEACAM4 Protein Lysate 20ug |
|||
 (OKCA00630)) CEACAM4 ELISA Kit (Human) (OKCA00630) |
|||
| OKCA00630 | Aviva Systems Biology | 96 Wells | EUR 999.6 |
|
Description: Description of target: Granulocyte orphan receptor that acts as an trigger efficient phagocytosis of attached particles.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 15.6 pg/mL |
|||
 CEACAM4 Peptide - N-terminal region |
|||
| MBS3232641-01mg | MyBiosource | 0.1mg | EUR 180 |
CEACAM4 Peptide - N-terminal region |
|||
| MBS3232641-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
 Human Over-expression Lysate) CEACAM4 (NM_001817) Human Over-expression Lysate |
|||
| E45H19648-2 | EnoGene | 20 ug | EUR 395 |
CEACAM4 (NM_001817) Human Over-expression Lysate |
|||
| LS001089 | BosterBio | 100ug | EUR 628 |
|
Description: Transient overexpression lysate of carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
 OCOA00621-20UG - CEACAM4 Protein Lysate |
|||
| OCOA00621-20UG | Aviva Systems Biology | 20ug | EUR 169 |
 CEACAM4 3'UTR GFP Stable Cell Line |
|||
| TU054157 | ABM | 1.0 ml | EUR 1672.8 |
) CEACAM4 sgRNA CRISPR Lentivector set (Human) |
|||
| K0426601 | ABM | 3 x 1.0 ug | EUR 406.8 |
 - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL) Lenti ORF particles, CEACAM4 (mGFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
| RC220740L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, CEACAM4 (mGFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
| RC220740L4V | Origene Technologies GmbH | 200 µl | Ask for price |
 - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL) Lenti ORF particles, CEACAM4 (Myc-DDK tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
| RC220740L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, CEACAM4 (Myc-DDK tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
| RC220740L3V | Origene Technologies GmbH | 200 µl | Ask for price |
 (pPM-C-HA)) CEACAM4 Protein Vector (Human) (pPM-C-HA) |
|||
| PV068795 | ABM | 500 ng | Ask for price |
 (pPB-C-His)) CEACAM4 Protein Vector (Human) (pPB-C-His) |
|||
| PV068793 | ABM | 500 ng | Ask for price |
 (pPB-N-His)) CEACAM4 Protein Vector (Human) (pPB-N-His) |
|||
| PV068794 | ABM | 500 ng | Ask for price |
 (pPM-C-His)) CEACAM4 Protein Vector (Human) (pPM-C-His) |
|||
| PV068796 | ABM | 500 ng | Ask for price |
 CEACAM4 3'UTR Luciferase Stable Cell Line |
|||
| TU004157 | ABM | 1.0 ml | EUR 1672.8 |
 (Target 1)) CEACAM4 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0426602 | ABM | 1.0 ug DNA | EUR 184.8 |
 (Target 2)) CEACAM4 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0426603 | ABM | 1.0 ug DNA | EUR 184.8 |
 (Target 3)) CEACAM4 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0426604 | ABM | 1.0 ug DNA | EUR 184.8 |
 Recombinant Human CEACAM4 Protein, His, E.coli-1mg |
|||
| QP5812-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
 Recombinant Human CEACAM4 Protein, His, E.coli-10ug |
|||
| QP5812-ec-10ug | EnQuireBio | 10ug | EUR 240 |
 Recombinant Human CEACAM4 Protein, His, E.coli-50ug |
|||
| QP5812-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
 Recombinant Human CEACAM4 Protein, His, Yeast-1mg |
|||
| QP5812-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
 Recombinant Human CEACAM4 Protein, His, E.coli-100ug |
|||
| QP5812-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
 Recombinant Human CEACAM4 Protein, His, E.coli-200ug |
|||
| QP5812-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
 Recombinant Human CEACAM4 Protein, His, E.coli-500ug |
|||
| QP5812-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
 Recombinant Human CEACAM4 Protein, His, Yeast-10ug |
|||
| QP5812-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
 Recombinant Human CEACAM4 Protein, His, Yeast-50ug |
|||
| QP5812-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
 Recombinant Human CEACAM4 Protein, His, Yeast-100ug |
|||
| QP5812-ye-100ug | EnQuireBio | 100ug | EUR 576 |
 Recombinant Human CEACAM4 Protein, His, Yeast-200ug |
|||
| QP5812-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
 Recombinant Human CEACAM4 Protein, His, Yeast-500ug |
|||
| QP5812-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
 AAP45182-100UG - CEACAM4 Peptide - N-terminal region |
|||
| AAP45182-100UG | Aviva Systems Biology | 100ug | EUR 99 |
-Avi-tagged) Recombinant Human CEACAM4 Protein, His (Fc)-Avi-tagged |
|||
| CEACAM4-571H | Creative BioMart | 50ug | EUR 2398.4 |
|
Description: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
|||
) Human Carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
| 1-CSB-YP005164HU | Cusabio |
|
|
|
Description: Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 4(CEACAM4),partial expressed in Yeast |
|||
Human Carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
| 1-CSB-EP005164HU | Cusabio |
|
|
|
Description: Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 4(CEACAM4),partial expressed in E.coli |
|||
 - 3 unique 27mer siRNA duplexes - 2 nmol each) Ceacam4 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR511381 | Origene Technologies GmbH | 2 nmol | Ask for price |
 CEACAM3/CEACAM6 Antibody |
|||
| 1-CSB-PA006209 | Cusabio |
|
|
|
Description: A polyclonal antibody against CEACAM3/CEACAM6. Recognizes CEACAM3/CEACAM6 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
|||
 CEACAM3 / CEACAM6 Antibody |
|||
| abx323361-100g | Abbexa | 100 µg | EUR 250 |
CEACAM3 / CEACAM6 Antibody |
|||
| 20-abx323361 | Abbexa |
|
|
CEACAM3 / CEACAM6 Antibody |
|||
| abx323361-50g | Abbexa | 50 µg | EUR 187.5 |
CEACAM3/CEACAM6 Antibody |
|||
| MBS7122421-005mg | MyBiosource | 0.05mg | EUR 150 |
CEACAM3/CEACAM6 Antibody |
|||
| MBS7122421-01mg | MyBiosource | 0.1mg | EUR 190 |
CEACAM3/CEACAM6 Antibody |
|||
| MBS7122421-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
 - 3 unique 27mer siRNA duplexes - 2 nmol each) CEACAM4 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR319693 | Origene Technologies GmbH | 2 nmol | Ask for price |
) CEACAM4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0426605 | ABM | 3 x 1.0 ug | EUR 451.2 |
 ELISA kit) Rat Carcinoembryonic antigen related cell adhesion molecule 4(CEACAM4) ELISA kit |
|||
| E01A11842 | BlueGene | 96T | EUR 700 |
|
Description: ELISA |
|||
HLA-DR-Constructive NK Cells Increase in Response to Mycobacterium Tuberculosis Antigens and Mediate Mycobacteria-Induced T Cell Activation
NK cells play an vital function within the management of tuberculosis an infection: they don’t seem to be solely in a position to kill the contaminated cells, but in addition management the exercise of macrophages and growth of the adaptive immune response. Nonetheless, there may be little data on the function of particular NK cell subsets on this community. On this research, we centered on the mycobacteria-driven responses of the NK cells expressing HLA-DR – a kind of MHC class II. Now we have revealed that this subset is elevated within the peripheral blood of sufferers with main recognized tuberculosis, and expands in response to in vitro stimulation with ultrasonically destroyed Mycobacterium tuberculosis cells (sonicate).
The expanded HLA-DR+ NK cells had much less differentiated phenotype, greater proliferative exercise and elevated expression of NKp30 and NKp46 receptors. HLA-DR+CD56dim NK cells confirmed greater IFNγ manufacturing and degranulation degree than the respective HLA-DR– NK cells in response to each 24 h and seven day stimulation with sonicate, whereas HLA-DR+CD56brilliant NK cells principally demonstarted comparable excessive responsiveness to the identical stimulating situations as their HLA-DR–CD56brilliant counterparts. After preliminary incubation with destroyed mycobacteria, cytokine-activated HLA-DR-expressing NK cells have been in a position to mediate mycobacteria-induced and HLA-DR-dependent cytokine manufacturing in autologous CD4+ T cells. Thus, functionally lively HLA-DR+ cells appear to be one of many NK cell subsets offering an vital hyperlink to the adaptive immunity.
Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
The receptor binding area (RBD) of the SARS-CoV-2 spike protein is the first goal of neutralizing antibodies and is a part of virtually all vaccine candidates. Right here, RBD immunogens have been created with stabilizing amino acid adjustments that enhance the neutralizing antibody response, in addition to traits for manufacturing, storage, and distribution. A computational design and in vitro screening platform recognized three improved immunogens, every with roughly 9 amino acid adjustments relative to the native RBD sequence and 4 key adjustments conserved between immunogens.
The adjustments are adaptable to all vaccine platforms, are suitable with established adjustments in SARS-CoV-2 vaccines, and are suitable with mutations in rising variants of concern. The immunogens elicit greater ranges of neutralizing antibodies than native RBD, focus the immune response to structured neutralizing epitopes, and have elevated manufacturing yields and thermostability. Incorporating these variant-independent amino acid adjustments in next-generation vaccines might improve the neutralizing antibody response and result in pan-SARS-CoV-2 safety.
Modulating T Follicular Cells In Vivo Enhances Antigen-Particular Humoral Immunity
Era of high-affinity IgG is crucial for protection towards infections and most cancers, which is the supposed consequence of many vaccines, however may cause autoimmune and inflammatory ailments when inappropriately directed towards self. The interaction of T follicular helper (TFH) cells and T follicular regulatory (TFR) cells is crucial for the manufacturing of high-affinity IgG of a selected subclass. On this research, we sought to enhance Ag-specific IgG responses with two interventions supposed to transiently diminish TFR cell affect. First, grownup mice have been administered an antibiotic combination (ABX) for an prolonged interval to deplete the immunoregulatory intestinal microbiota.
This intriguingly elevated TFH cell and decreased TFR cell numbers. 2,4,6-Trinitrophenyl hapten conjugated to keyhole limpet hemocyanin immunization resulted in greater affinity 2,4,6-trinitrophenyl hapten-specific IgG1 in ABX mice in contrast with controls. In a mannequin of IgG-driven inflammatory nephritis, ABX mice had considerably worse nephritis accompanied by greater affinity Ag-specific IgG2b and enriched TFH cells in contrast with controls. Second, we sought to functionally manipulate TFH and TFR cells, which each categorical the checkpoint inhibitory molecule, PD-1, by administration of anti-PD-1 throughout immunization. This intervention enhanced the affinity of Ag-specific IgG of the applicable subclass and elevated in TFH cells following 2,4,6-trinitrophenyl hapten conjugated to keyhole limpet hemocyanin immunization and nephritis induction. These outcomes counsel that altering TFH and TFR cell ratios throughout immunization is an interesting technique to qualitatively enhance Ag- and subclass-specific IgG responses.
Human delta like 1-expressing human mesenchymal stromal cells promote human T cell growth and antigen-specific response in humanized NOD/SCID/IL-2R[Formula: see text] null (NSG) mice
Human delta-like 1 (hDlk1) is understood to have the ability to regulate cell destiny choices throughout hematopoiesis. Mesenchymal stromal cells (MSCs) are identified to exhibit potent immunomodulatory roles in quite a lot of ailments. Herein, we investigated in vivo capabilities of hDlk1–hMSCs and hDlk1+hMSCs in T cell growth and T cell response to viral an infection in humanized NOD/SCID/IL-2Rγnull (NSG) mice. Co-injection of hDlk1–hMSC with hCD34+ wire blood (CB) cells into the liver of NSG mice markedly suppressed the event of human T cells. In distinction, co-injection of hDlk1+hMSC with hCD34+ CB cells into the liver of NSG dramatically promoted the event of human T cells. Human T cells developed in humanized NSG mice symbolize markedly various, functionally lively, TCR V[Formula: see text] usages, and the restriction to human MHC molecules.
Upon problem with Epstein-Barr virus (EBV), EBV-specific hCD8+ T cells in humanized NSG mice have been successfully mounted with phenotypically activated T cells introduced as hCD45+hCD3+hCD8+hCD45RO+hHLA-DR+ T cells, suggesting that antigen-specific T cell response was induced within the humanized NSG mice. Taken collectively, our knowledge counsel that the hDlk1-expressing MSCs can successfully promote the event of human T cells and immune response to exogenous antigen in humanized NSG mice. Thus, the humanized NSG mannequin might need potential benefits for the event of therapeutics concentrating on infectious ailments sooner or later.
 Hepatitis B Surface Antigen Antibody |
|||
| GWB-3A4AD9 | GenWay Biotech | 1 ml | Ask for price |
 Hepatitis B surface antigen Antibody |
|||
| GWB-2BFAD2 | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
| GWB-3250E0 | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B Surface Antigen Antibody |
|||
| GWB-118855 | GenWay Biotech | 1 ml | Ask for price |
Hepatitis B surface antigen Antibody |
|||
| GWB-1771DC | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
| GWB-18B7D0 | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
| GWB-195209 | GenWay Biotech | 0.5 mg | Ask for price |
Hepatitis B Surface Antigen Antibody |
|||
| GWB-F21AB1 | GenWay Biotech | 1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
| GWB-F44C6A | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B Surface Antigen Antibody |
|||
| GWB-D8AC18 | GenWay Biotech | 0.2 mg | Ask for price |
) Hepatitis B Surface Antigen Antibody (HRP) |
|||
| GWB-7F64AF | GenWay Biotech | 0.1 mg | Ask for price |
 Hepatitis B - surface antigen |
|||
| MBS324120-1mL | MyBiosource | 1mL | EUR 315 |
Hepatitis B - surface antigen |
|||
| MBS324120-5x1mL | MyBiosource | 5x1mL | EUR 1320 |
Hepatitis B - surface antigen |
|||
| MBS324121-1mL | MyBiosource | 1mL | EUR 325 |
Hepatitis B - surface antigen |
|||
| MBS324121-5x1mL | MyBiosource | 5x1mL | EUR 1375 |
Hepatitis B - surface antigen |
|||
| MBS324122-1mL | MyBiosource | 1mL | EUR 345 |
Hepatitis B - surface antigen |
|||
| MBS324122-5x1mL | MyBiosource | 5x1mL | EUR 1465 |
 Hepatitis B surface antigen |
|||
| MBS324123-1mL | MyBiosource | 1mL | EUR 395 |
Hepatitis B surface antigen |
|||
| MBS324123-5x1mL | MyBiosource | 5x1mL | EUR 1685 |
Hepatitis B - surface antigen |
|||
| MBS324124-1mL | MyBiosource | 1mL | EUR 325 |
Hepatitis B - surface antigen |
|||
| MBS324124-5x1mL | MyBiosource | 5x1mL | EUR 1375 |
Hepatitis B - surface antigen |
|||
| MBS324125-1mL | MyBiosource | 1mL | EUR 325 |
Hepatitis B - surface antigen |
|||
| MBS324125-5x1mL | MyBiosource | 5x1mL | EUR 1375 |
Hepatitis B - surface antigen |
|||
| MBS324126-1mL | MyBiosource | 1mL | EUR 340 |
Hepatitis B - surface antigen |
|||
| MBS324126-5x1mL | MyBiosource | 5x1mL | EUR 1425 |
Hepatitis B - surface antigen |
|||
| MBS324127-1mL | MyBiosource | 1mL | EUR 360 |
Hepatitis B - surface antigen |
|||
| MBS324127-5x1mL | MyBiosource | 5x1mL | EUR 1520 |
Hepatitis B - surface antigen |
|||
| MBS324128-1mL | MyBiosource | 1mL | EUR 340 |
Hepatitis B - surface antigen |
|||
| MBS324128-5x1mL | MyBiosource | 5x1mL | EUR 1425 |
Hepatitis B surface antigen |
|||
| MBS320112-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
| MBS320112-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
| MBS320113-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
| MBS320113-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
| MBS320114-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
| MBS320114-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
| MBS320115-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
| MBS320115-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
| MBS320116-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
| MBS320116-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
 Hepatitis B Surface Antigen |
|||
| MBS6507653-01mg | MyBiosource | 0.1mg | EUR 555 |
Hepatitis B Surface Antigen |
|||
| MBS6507653-5x01mg | MyBiosource | 5x0.1mg | EUR 2355 |
) Hepatitis B Surface Antigen Antibody (Ad/Ay) |
|||
| GWB-406C01 | GenWay Biotech | 1 ml | Ask for price |
Hepatitis B Surface Antigen Antibody (Ad/Ay) |
|||
| GWB-B67323 | GenWay Biotech | 0.2 mg | Ask for price |
 Antibody) Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021777-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021777-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021777-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021778-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021778-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021778-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021779-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021779-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021779-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021780-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021780-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021780-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021781-1mg | Abbexa | 1 mg | EUR 1178.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021781-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021781-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021782-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021782-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021782-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021783-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021783-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021783-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021784-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021784-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021784-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021785-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021785-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021785-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021786-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021786-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021786-80l | Abbexa | 80 µl | EUR 725 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021806-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021806-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021806-80l | Abbexa | 80 µl | EUR 687.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021807-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021807-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021807-80l | Abbexa | 80 µl | EUR 687.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021808-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021809-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021809-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021809-80l | Abbexa | 80 µl | EUR 662.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021810-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021810-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021810-80l | Abbexa | 80 µl | EUR 762.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021811-1mg | Abbexa | 1 mg | EUR 777.6 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021811-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021811-80l | Abbexa | 80 µl | EUR 825 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021812-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021812-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021812-80l | Abbexa | 80 µl | EUR 762.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021814-1mg | Abbexa | 1 mg | EUR 1387.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021814-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021814-80l | Abbexa | 80 µl | EUR 375 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021815-1mg | Abbexa | 1 mg | EUR 1387.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021815-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021815-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021816-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021816-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021816-80l | Abbexa | 80 µl | EUR 687.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021817-100ug | Abbexa | 100 ug | EUR 794.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021817-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021817-80l | Abbexa | 80 µl | EUR 725 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021818-1mg | Abbexa | 1 mg | EUR 777.6 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021818-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021818-80l | Abbexa | 80 µl | EUR 825 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021819-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021820-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021821-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021821-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021821-80l | Abbexa | 80 µl | EUR 637.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx021823-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx022999-1mg | Abbexa | 1 mg | EUR 577.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023004-1mg | Abbexa | 1 mg | EUR 811.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023006-1ml | Abbexa | 1 ml | EUR 777.6 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023006-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023006-80l | Abbexa | 80 µl | EUR 1050 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023007-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023007-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023007-80l | Abbexa | 80 µl | EUR 975 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx023848-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx342052-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx342052-50l | Abbexa | 50 µl | EUR 2575 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx342091-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx342091-50l | Abbexa | 50 µl | EUR 2575 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx239778-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx239778-100ug | Abbexa | 100 ug | EUR 577.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx239778-50l | Abbexa | 50 µl | EUR 387.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx240304-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx240304-50l | Abbexa | 50 µl | EUR 350 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
| abx376359-96tests | Abbexa | 96 tests | EUR 225 |
 Hepatitis B Virus Surface Antigen Antibody |
|||
| 20-abx134235 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody |
|||
| 20-abx134236 | Abbexa |
|
|
 Hepatitis B Virus surface antigen Antibody |
|||
| GWB-4BAE14 | GenWay Biotech | 1 ml | Ask for price |
 Hepatitis A Surface Antigen Antibody |
|||
| GWB-8A0702 | GenWay Biotech | 0.2 mg | Ask for price |
Hepatitis A Surface Antigen Antibody |
|||
| GWB-DFB8F4 | GenWay Biotech | 0.2 mg | Ask for price |
 HEPATITIS B SURFACE ANTIGEN AY |
|||
| GWB-F1CE5F | GenWay Biotech | 0.1 mg | Ask for price |
 Antibody (HRP)) Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx021776-1mg | Abbexa | 1 mg | EUR 1296 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx021776-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx021776-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx021822-1mg | Abbexa | 1 mg | EUR 1296 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx023002-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx023002-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx023002-80l | Abbexa | 80 µl | EUR 1112.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx023005-1ml | Abbexa | 1 ml | EUR 886.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx023005-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
| abx023005-80l | Abbexa | 80 µl | EUR 1175 |
 (FITC)) Hepatitis B Surface Antigen Antibody (AD/AY) (FITC) |
|||
| GWB-ABE5A1 | GenWay Biotech | 1 ml | Ask for price |
 Antibody (FITC)) Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
| abx023001-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
| abx023001-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
| abx023001-80l | Abbexa | 80 µl | EUR 1112.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
| abx023009-1ml | Abbexa | 1 ml | EUR 844.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
| abx023009-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
| abx023009-80l | Abbexa | 80 µl | EUR 1175 |
 Antibody Pair) Hepatitis B Surface Antigen (HBsAg) Antibody Pair |
|||
| abx137761-100l | Abbexa | 100 µl | EUR 350 |
Hepatitis B Surface Antigen (HBsAg) Antibody Pair |
|||
| abx137761-500l | Abbexa | 500 µl | EUR 950 |
) Hepatitis B Surface Antigen Antibody (ready to use) |
|||
| GWB-95C198 | GenWay Biotech | 6 ml | Ask for price |
) Hepatitis B Virus Surface Antigen Antibody (HRP) |
|||
| 20-abx134237 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (HRP) |
|||
| 20-abx134238 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (HRP) |
|||
| GWB-475DB7 | GenWay Biotech | 0.1 ml | Ask for price |
 OASA00809-200UG - HEPATITIS B SURFACE ANTIGEN Antibody |
|||
| OASA00809-200UG | Aviva Systems Biology | 0.2mg | EUR 459 |
 OASA00814-100UG - HEPATITIS B SURFACE ANTIGEN Antibody |
|||
| OASA00814-100UG | Aviva Systems Biology | 0.1mg | EUR 469 |
 HBsAg, Hepatitis B Surface Antigen |
|||
| MBS397225-1mL | MyBiosource | 1mL | EUR 475 |
HBsAg, Hepatitis B Surface Antigen |
|||
| MBS397225-5x1mL | MyBiosource | 5x1mL | EUR 1985 |
) Hepatitis B Surface Antigen (HBsAg) |
|||
| MBS6507654-1mL | MyBiosource | 1mL | EUR 510 |
Hepatitis B Surface Antigen (HBsAg) |
|||
| MBS6507654-5x1mL | MyBiosource | 5x1mL | EUR 2135 |
 Antibody (Biotin)) Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
| abx023000-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
| abx023000-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
| abx023000-80l | Abbexa | 80 µl | EUR 1050 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
| abx023008-1ml | Abbexa | 1 ml | EUR 844.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
| abx023008-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
| abx023008-80l | Abbexa | 80 µl | EUR 1087.5 |
) Hepatitis B Virus Surface Antigen Antibody (FITC) |
|||
| 20-abx134239 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (FITC) |
|||
| 20-abx134240 | Abbexa |
|
|
) Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
| 20-abx134241 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
| 20-abx134242 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
| GWB-A855CE | GenWay Biotech | 0.1 ml | Ask for price |
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
| GWB-13CFC6 | GenWay Biotech | 0.1 ml | Ask for price |
 Antibody (ad/ay)) Hepatitis B Surface Antigen (HBsAg) Antibody (ad/ay) |
|||
| GWB-T00719 | GenWay Biotech | 1 mg | Ask for price |
 Antibody, Concentrate) Hepatitis B,surface Antigen, (HbsAg) Antibody, Concentrate |
|||
| PAB361C | Innovex | 0.2ml | EUR 455 |
 (FITC)) Hepatitis B Antibody (Virus Surface Antigen) (FITC) |
|||
| GWB-8ABE07 | GenWay Biotech | 0.1 ml | Ask for price |
 Recombinant Hepatitis B Surface Antigen |
|||
| DAG435 | Creative Diagnostics | 100ug | EUR 673.31 |
|
Description: Recombinant |
|||
 Antibody) Hepatitis B Virus Surface Antigen (HBsAg) Antibody |
|||
| abx137498-100tests | Abbexa | 100 tests | EUR 225 |
Hepatitis B Virus Surface Antigen (HBsAg) Antibody |
|||
| 20-abx137498 | Abbexa |
|
|
 (AP)) Hepatitis B Surface Antigen (HBsAg) (AP) |
|||
| MBS6260170-01mL | MyBiosource | 0.1mL | EUR 1535 |
Hepatitis B Surface Antigen (HBsAg) (AP) |
|||
| MBS6260170-5x01mL | MyBiosource | 5x0.1mL | EUR 6765 |
Hepatitis B Surface Antigen (HBsAg) (AP) |
|||
| MBS6260171-01mL | MyBiosource | 0.1mL | EUR 800 |
Hepatitis B Surface Antigen (HBsAg) (AP) |
|||
| MBS6260171-5x01mL | MyBiosource | 5x0.1mL | EUR 3450 |
Hepatitis B Surface Antigen (HBsAg) (AP) |
|||
| MBS6260250-01mL | MyBiosource | 0.1mL | EUR 800 |
Hepatitis B Surface Antigen (HBsAg) (AP) |
|||
| MBS6260250-5x01mL | MyBiosource | 5x0.1mL | EUR 3450 |
 (PE)) Hepatitis B Surface Antigen (HBsAg) (PE) |
|||
| MBS6262721-01mL | MyBiosource | 0.1mL | EUR 1535 |
Hepatitis B Surface Antigen (HBsAg) (PE) |
|||
| MBS6262721-5x01mL | MyBiosource | 5x0.1mL | EUR 6765 |
Hepatitis B Surface Antigen (HBsAg) (PE) |
|||
| MBS6262722-01mL | MyBiosource | 0.1mL | EUR 800 |
Hepatitis B Surface Antigen (HBsAg) (PE) |
|||
| MBS6262722-5x01mL | MyBiosource | 5x0.1mL | EUR 3450 |
